Diabetic Neuropathy
Diabetic neuropathy is a type of nerve and blood vessel damage caused by high blood glucose levels in diabetes, resulting in symptoms such as numbness, tingling, pain, urinary problems, sexual dysfunction, and dizziness. It can involve various forms of nerve damage including distal symmetric polyneuropathy, cranial nerve palsies, mononeuropathies, and autonomic neuropathy.
Health Outcomes
- Beneficial Clinical Effects
- Elevated Redox Status
- Enhanced Antioxidant Capabilities
- Enhanced Metabolite Levels
- Enhanced Radical Scavenging Ability
- Improved Antioxidant Enzyme Levels
- Improved Blood Glucose Levels
- Improved Corneal Nerve Length
- Improved Corneal Nerve Reflectivity
- Improved Corneal Nerve Width
- Improved Diabetic Foot Ulcer Healing
- Improved Metabolic Regulation
- Improved Neuropathy
- Improved Neuropathy Symptom Score
- Improved Pain Score
- Improved Peripheral Nervous System Disease
- Improved Superoxide Dismutase Activity
- Increase in Persistent Diseased Sites
- Increased Antioxidant Enzyme Levels
- Increased Antioxidant Potential
- Increased Burning Sensation
- Increased Oxidative Stress Tolerance
- Increased PPAR-γ Activity
- Increased Serum Glucose Levels
- Inhibited Absorption of Advanced Glycation End-products (AGEs)
- Modulated Metabolite Profile
- Modulated Nociceptive Signaling
- No Change in Overall Glucose Response
- Protection Against Oxidative Stress
- Reduced Advanced Glycation End Product Level
- Reduced Blood Glucose Elevation
- Reduced Carboxymethyl Lysine
- Reduced Colonic Contraction Frequency
- Reduced Corneal Neuroma
- Reduced Days with Defecation Urgency
- Reduced Diabetic Complications
- Reduced Diabetic Neuropathic Pain
- Reduced Diabetic Peripheral Neuropathy
- Reduced Dietary Advanced Glycation End Product Intake
- Reduced Gastric Emptying
- Reduced Gastric Emptying Time
- Reduced Glucotoxicity
- Reduced Glutathione Redox Ratio
- Reduced Glycation End Product Accumulation
- Reduced Incidence of Adverse Events
- Reduced Muscle Cramp Duration
- Reduced Neurogenic Pain
- Reduced Neurological Symptoms
- Reduced Neuropathic Pain
- Reduced Neuropathy Total Symptom Score
- Reduced Pain Intensity
- Reduced Pain Sensitivity
- Reduced Pain Severity
- Reduced Peripheral Neuropathy Grade
- Reduced Physiological Impairments
- Reduced Serum Levels of CML
- Reduced Serum Malondialdehyde Levels
- Reduced Skin Sensitivity
- Reduced Sour Taste Perception
- Reduced Thermal Pain Sensation
- Reduced Urgency
- Reduction of Diabetes-Induced Organ Damage
- Stabilized Amino Acid Metabolism
- Stabilized Hemoglobin A1c Level